Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Curaleaf Holdings Inc

Healthcare US CURLF

3.67USD
0.26(7.62%)

Last update at 2026-06-04T19:59:00Z

Day Range

3.373.80
LowHigh

52 Week Range

0.725.05
LowHigh

Fundamentals

  • Previous Close 3.41
  • Market Cap2368.69M
  • Volume212722
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA222.06M
  • Revenue TTM1268.14M
  • Revenue Per Share TTM1.66
  • Gross Profit TTM 631.02M
  • Diluted EPS TTM-0.32

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -78.21400M -113.35800M -124.36600M -226.42900M 64.80M
Minority interest -2.91700M 6.58M 9.14M 6.83M 7.40M
Net income -273.36400M -238.16900M -281.19700M -370.09800M -101.73100M
Selling general administrative 458.07M 438.60M 434.78M 475.56M 415.74M
Selling and marketing expenses - - - - -
Gross profit 631.02M 640.78M 614.45M 579.03M 687.59M
Reconciled depreciation 216.04M 248.02M 211.91M 176.47M 132.64M
Ebit - - - - 175.63M
Ebitda - - - 43.37M 287.70M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 25.45M 24.74M 42.88M -12.37200M 175.63M
Other operating expenses - - - - -
Interest expense 100.83M 100.62M 100.38M 93.33M 90.26M
Tax provision 123.69M 98.25M 114.59M 150.50M 173.93M
Interest income 0.66M 0.78M 0.02M 0.14M 0.63M
Net interest income -100.16600M -99.84000M -100.35900M -93.19300M -89.63300M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - 173.93M
Total revenue 1268.13M 1334.30M 1346.63M 1336.34M 1209.66M
Total operating expenses 1242.68M 1309.56M 1303.75M 1348.71M 1034.03M
Cost of revenue 637.11M 693.52M 732.18M 757.31M 522.07M
Total other income expense net -3.49800M -38.26100M -66.89000M -120.86400M -21.20500M
Discontinued operations - - - - -
Net income from continuing ops -244.19700M -234.35500M -238.95500M -376.93100M -109.13000M
Net income applicable to common shares - - - - -101.73100M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2845.32M 2949.54M 3096.58M 3397.92M 3262.48M
Intangible assets 1011.12M 1085.40M 1172.44M 1217.19M 1010.01M
Earning assets - - - - -
Other current assets 37.38M 28.13M 30.40M 32.30M 80.58M
Total liab 2005.03M 1956.14M 1925.28M 1997.10M 1453.99M
Total stockholder equity 840.28M 993.39M 1171.29M 1279.70M 1757.26M
Deferred long term liab - - - - -
Other current liab 19.93M 20.07M 28.11M 41.34M 179.82M
Common stock - - - - 2225.94M
Capital stock 0.00000M 0.00000M 0.00000M 0.00000M 2225.94M
Retained earnings -1587.24400M -1356.17400M -1140.75100M -859.55600M -291.39500M
Other liab - - - - 406.19M
Good will 635.12M 628.88M 626.63M 625.13M 605.50M
Other assets - - - - 25.48M
Cash 89.17M 93.03M 91.82M 163.18M 299.33M
Cash and equivalents - - - - -
Total current liabilities 294.31M 387.93M 494.03M 491.08M 315.40M
Current deferred revenue - - - - -
Net debt 459.48M 475.59M 495.95M 459.64M 136.76M
Short term debt - - - - -
Short long term debt 35.73M 101.72M 39.48M 51.96M 1.97M
Short long term debt total - - - - -
Other stockholder equity - - - - -172.08100M
Property plant equipment - - - - 664.83M
Total current assets 448.62M 429.68M 418.60M 605.33M 952.26M
Long term investments 0.26M 14.98M 2.48M 2.80M 4.40M
Net tangible assets - - - - 141.75M
Short term investments - - - - -
Net receivables 73.86M 63.99M 60.00M 52.16M 66.89M
Long term debt 512.92M 466.90M 548.29M 570.86M 434.12M
Inventory 225.02M 220.65M 215.91M 250.64M 469.80M
Accounts payable 74.72M 79.13M 79.32M 85.26M 26.75M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.05M 2.95M 12.57M 48.22M 22.05M
Deferred long term asset charges - - - - -
Non current assets total 2396.69M 2519.86M 2677.97M 2792.59M 2310.22M
Capital lease obligations 278.31M 285.20M 295.78M 309.09M 317.56M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -0.17300M -0.70800M -0.70800M -228.62300M -163.97400M
Change to liabilities - - - - -10.29800M
Total cashflows from investing activities - - - - -163.97400M
Net borrowings -34.16500M -42.54400M -42.54400M - 135.99M
Total cash from financing activities -73.49300M -54.09400M -54.09400M 50.54M 424.80M
Change to operating activities - - - - -3.55200M
Net income -273.36400M -215.42300M -281.19700M -370.09800M -101.73100M
Change in cash -6.13100M 15.56M 15.56M -131.68300M 225.79M
Begin period cash flow 107.23M 91.82M 91.82M 299.33M 73.54M
End period cash flow 101.57M 107.23M 107.23M - 299.33M
Total cash from operating activities 137.71M 163.62M 163.62M 46.40M -33.96400M
Issuance of capital stock - 0.00000M 11.50M 0.00000M 240.57M
Depreciation 216.04M 248.02M 248.02M 176.47M 131.76M
Other cashflows from investing activities - - - - 1.47M
Dividends paid - - - - -
Change to inventory -3.72400M 4.31M 4.31M 31.24M -105.19300M
Change to account receivables -10.96100M -7.79100M -7.79100M 7.96M -29.40200M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - 53.40M
Change to netincome - - - - 23.80M
Capital expenditures 64.65M 97.44M 97.44M 138.36M 171.96M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 120.39M 105.49M 105.49M 110.21M -88.67700M
Stock based compensation 35.74M 25.70M 25.70M 28.02M 45.63M
Other non cash items 6.24M 12.01M 12.01M 11.61M -54.67900M
Free cash flow 73.06M 66.19M 66.19M -91.96100M -205.91900M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CURLF
Curaleaf Holdings Inc		 0.26 7.62% 3.67 - 138.89 1.87 3.15 2.45 13.03
ZTS
Zoetis Inc		 1.93 2.49% 79.52 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 1.31 4.22% 32.32 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 14.53 9.74% 163.71 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 -0.34 0.83% 40.58 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.

Curaleaf Holdings Inc

290 Harbor Drive, Stamford, CT, United States, 06902

Key Executives

Name Title Year Born
Mr. Boris Alexis Jordan Exec. Chairman 1966
Mr. Joseph F. Lusardi Exec. Vice-Chairman 1974
Mr. Joseph Daniel Bayern Exec. Officer & Exec. of New Markets 1963
Mr. Matthew S. Darin Chief Exec. Officer NA
Mr. Edward Kremer Chief Financial Officer 1972
Mr. Joe Holland Exec. VP of Operations NA
Mr. Camilo Russi Lyon Chief Investment Officer NA
Mr. Jakob Feinstein Mang. of Investor Relations NA
Mr. Peter Clateman J.D. Chief Legal Officer 1968
Mr. James S. Shorris Chief Compliance Officer 1962

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.